Tag: Medical Innovation Award

Weitao Man | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Weitao Man | Medicine and Dentistry | Best Researcher Award

Neurosurgeon From Tsinghua University, China

Dr. Weitao Man is a distinguished attending physician in neurosurgery and an associate researcher at Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China. His expertise spans various areas of neurosurgery, particularly focusing on spinal cord injury, neurodegenerative diseases, and neurophysiology. With a solid academic background and clinical experience, Dr. Man has contributed extensively to the advancement of neuroscientific research and clinical treatments, particularly through his innovative work on biomaterials and regenerative medicine. His clinical approach integrates cutting-edge research findings with a compassionate patient care model, making him a prominent figure in his field.

Professional Profile

Education

Dr. Man’s educational journey began at Southern Medical University in Guangzhou, China, where he earned his Bachelor of Clinical Medicine in 2012. He further pursued his passion for neurosurgery, completing a Master’s in Neurosurgery from Capital Medical University in 2015. In 2021, he obtained his Ph.D. in Medicine from Tsinghua University under the mentorship of Professor Guihuai Wang. His rigorous academic training has laid the foundation for his exceptional contributions to the field of neurosurgery, focusing on spinal cord injury and neuroregenerative medicine.

Professional Experience

Dr. Man has a broad and distinguished career in both clinical practice and research. Currently, he serves as an attending neurosurgeon and associate researcher at Beijing Tsinghua Changgung Hospital, a role he has held since 2023. His earlier experiences include a post-doctoral fellowship at Massachusetts General Hospital, Harvard Medical School, and residency positions in renowned hospitals such as Sanbo Brain Hospital and Beijing Tsinghua Changgung Hospital. His career reflects a blend of hands-on clinical work and high-level scientific investigation, contributing to advancements in the field of neurosurgery.

Research Interests

Dr. Man’s primary research interests lie in the areas of spinal cord injury, neurodegenerative diseases, and the development of innovative biomaterials for neurosurgery. He is particularly focused on the molecular mechanisms of microglial polarization and its role in spinal cord regeneration. His work also includes the development of hydrogels and biomimetic exosomes as potential therapies for spinal cord injury. Dr. Man’s research bridges the gap between basic science and clinical application, aiming to improve the quality of life for patients suffering from neurological disorders.

Research Skills

Dr. Man is skilled in a wide array of advanced research techniques, including molecular biology, tissue engineering, and biocompatible material development. He has experience in utilizing animal models for neurodegenerative disease research and spinal cord injury repair. His expertise also extends to advanced imaging techniques, such as ultrafast power Doppler imaging, and the development of innovative biomaterials like conductive hydrogels for neural interfaces. These skills, combined with his strong analytical background, enable him to contribute significantly to both experimental research and clinical applications.

Awards and Honors

Throughout his career, Dr. Man has received numerous accolades for his groundbreaking work in neurosurgery and neuroregenerative medicine. His work on neurodegenerative diseases, particularly Parkinson’s disease and spinal cord injury, has garnered attention in prestigious medical journals and conferences. Dr. Man’s ability to combine clinical expertise with pioneering research has earned him recognition both in China and internationally, including funding from the Natural Science Foundation of China and the Beijing Natural Science Foundation for his research on spinal cord injury regeneration.

Conclusion

Dr. Weitao Man is a highly accomplished neurosurgeon and researcher whose career reflects a profound commitment to advancing the field of neurosurgery. His combination of clinical expertise, cutting-edge research, and dedication to patient care makes him a leader in his field. Through his research on spinal cord injury, neurodegenerative diseases, and neuroregenerative therapies, Dr. Man continues to make significant contributions toward improving the outcomes for patients with neurological disorders. His work promises to shape the future of neurosurgery and regenerative medicine for years to come.

Publications Top Notes

  • Title: 3D Bioprinted Dynamic Bioactive Living Construct Enhances Mechanotransduction-Assisted Rapid Neural Network Self-Organization for Spinal Cord Injury Repair

    • Authors: J. Yang, K. Kim, Y. Liu, K. Yang, X. Wang

    • Year: 2025

  • Title: Electroacupuncture Ameliorated Locomotor Symptoms in MPTP-Induced Mice Model of Parkinson’s Disease by Regulating Autophagy via Nrf2 Signaling

    • Authors: J. Zhang, Z. Fu, F. Wen, X. Sun, Y. Huang

    • Year: 2025

Rohidas Arote | Pharmaceutical Science | Biotechnology Advancement Award

Published on by World Science Awards

Prof. Rohidas Arote | Pharmaceutical Science | Biotechnology Advancement Award

Dr. Rohidas B. Arote is a distinguished professor in the Center for Nano and Material Sciences at Jain University, Bangalore, India. With over two decades of experience in biotechnology, gene therapy, and drug delivery, he has made substantial contributions to biomedical research. His expertise lies in biomaterials, pharmacology, toxicology, and theranostics, particularly in cancer, immune, and regenerative therapies. Having served as a professor at Seoul National University (SNU), a globally ranked institution, he has led groundbreaking research in non-viral gene delivery systems and targeted drug delivery for cancer therapy. Dr. Arote has secured major research grants, collaborated with international institutions, and delivered invited talks at global conferences. He has received prestigious awards such as the Creative Pioneering Research Award and IAAM Scientist Medal. In addition to his academic achievements, he actively contributes to international scientific societies, reviews for high-impact journals, and organizes leading scientific conferences. With a strong track record of publications, research funding, and innovation, Dr. Arote continues to be a key figure in biomedical and pharmaceutical sciences, advancing cutting-edge solutions for healthcare and drug development.

Professional Profile

Education

Dr. Rohidas B. Arote holds a Ph.D. in Biotechnology (2009) from Seoul National University, South Korea, where he specialized in gene therapy and drug delivery systems. His doctoral research focused on developing non-viral polymeric gene carriers for targeted cancer therapy. Before pursuing his Ph.D., he earned a Master of Science (M.S.) in Pharmacognosy and Phytochemistry (2002) from the University of Mumbai, India, where he gained expertise in natural product chemistry and pharmaceutical formulations. His academic journey began with a Bachelor of Science (B.S.) in Pharmaceutical Sciences (2000) from the University of Pune, India, equipping him with a strong foundation in pharmaceutics, drug formulation, and biotechnology. Throughout his education, he has been a recipient of several prestigious fellowships, including the Brain Korea (BK21) Fellowship (2008) and the Korea Science and Engineering Fellowship (KOSEF) (2005). He was also a GATE Scholar in Pharmacy (2000), a competitive national-level qualification exam conducted by IIT Kharagpur, India. His interdisciplinary academic background, spanning biotechnology, pharmaceutical sciences, and biomedical engineering, has enabled him to develop innovative solutions in gene therapy, biomaterials, and targeted drug delivery.

Professional Experience

Dr. Rohidas B. Arote has over 20 years of academic and research experience across prestigious institutions worldwide. He is currently a Professor at the Center for Nano and Material Sciences, Jain University, Bangalore (2021-present), where he leads cutting-edge research in nanomedicine and biomaterials. Prior to this, he served at Seoul National University (SNU), South Korea, as an Associate Professor (2017-2020) and Assistant Professor (2010-2017), where he developed gene delivery technologies for cancer therapy. He also worked as a Research Associate (2009-2010) at SNU, focusing on polymeric carriers for gene therapy. In addition, he held visiting professor positions at King Abdullah University of Science and Technology (KAUST), Saudi Arabia (2019-2020), and the Indian Institute of Science (IISc), Bangalore (2019-2020), contributing to advanced biomedical research. Early in his career, he gained industry experience as a Formulation & Development Scientist at Ajanta Pharma Ltd, Mumbai (2003-2004). His diverse academic, research, and industry experience has made him a leader in drug delivery, biomaterials, and biomedical engineering.

Research Interests

Dr. Rohidas B. Arote’s research focuses on gene therapy, drug delivery, biomaterials, biomedical engineering, pharmacology, toxicology, and theranostics. He is particularly interested in developing novel non-viral gene delivery systems for targeted cancer therapy. His work involves designing biodegradable polymeric nanocarriers for effective gene transfection, with applications in cancer, immune, and regenerative therapies. He explores nanotechnology-based drug delivery to enhance the bioavailability and therapeutic efficacy of pharmaceuticals. Additionally, he investigates biocompatible materials for tissue engineering and regenerative medicine, contributing to the development of next-generation biomaterials for medical applications. His interdisciplinary research bridges biotechnology, materials science, and pharmaceutical sciences, addressing critical challenges in disease treatment and drug delivery. Through collaborations with global research institutions, he continues to push the boundaries of biomedical research by integrating nanomedicine, molecular biology, and bioengineering to develop innovative therapeutic strategies.

Research Skills

Dr. Rohidas B. Arote possesses a diverse set of advanced research skills in biomedical and pharmaceutical sciences. He is an expert in nanotechnology-based drug delivery, specializing in the synthesis and characterization of biodegradable polymers for gene therapy applications. He has expertise in molecular biology techniques, including gene cloning, siRNA delivery, and CRISPR-based genome editing. His skills extend to polymeric biomaterials design, nanoparticle synthesis, and surface modification for targeted drug delivery. He is proficient in in vitro and in vivo models for evaluating gene expression, drug efficacy, and toxicity in preclinical studies. Additionally, he has experience in high-throughput screening, bioinformatics, and computational modeling for drug formulation optimization. His research involves the development of multifunctional polymeric carriers, receptor-mediated drug targeting, and biodegradable materials for regenerative medicine. His strong analytical and problem-solving abilities have enabled him to successfully secure research funding, publish in top-tier scientific journals, and contribute to cutting-edge biomedical innovations.

Awards and Honors

Dr. Rohidas B. Arote has received numerous prestigious awards for his pioneering research in gene therapy and biomaterials. He was honored with the Creative Pioneering Research Award (2017) from Seoul National University, recognizing his innovative contributions to biomedical research. He also received the IAAM Scientist Medal (2017) from the International Association of Advanced Materials, highlighting his excellence in advanced materials and nanomedicine. Other notable accolades include the Research Excellence Award (2010) from the Research Institute for Agriculture and Life Sciences and the Young Scientist Award (2008) from the 16th POLYCHAR: World Forum on Advanced Materials. He has been a Brain Korea (BK21) Fellow (2008) and received the Korea Science and Engineering Fellowship (KOSEF) (2005). His early academic achievements include being a GATE Scholar in Pharmacy (2000), a highly competitive national-level distinction. These awards reflect his outstanding research contributions, leadership in academia, and dedication to advancing biomedical sciences.

Conclusion

Dr. Rohidas B. Arote is an exceptional researcher and academic leader with a remarkable career spanning over two decades in biotechnology, gene therapy, and drug delivery. His contributions in biomaterials, nanomedicine, and regenerative therapies have significantly advanced the field of biomedical sciences. Through his research, funding acquisitions, and scientific collaborations, he has played a crucial role in developing novel drug delivery systems for cancer therapy. His achievements in securing high-impact publications, international awards, and research grants showcase his dedication to scientific excellence. In addition to his research, he has contributed as a peer reviewer, conference organizer, and mentor, shaping the next generation of biomedical researchers. As a professor at Jain University, Bangalore, and a former faculty member at Seoul National University, he continues to lead groundbreaking research in nanomedicine. With his strong academic background, innovative research, and global scientific impact, Dr. Arote stands as a deserving candidate for prestigious research awards, making a lasting impact in healthcare and pharmaceutical sciences.

Publications Top Notes

  1. Title: Microfluidics in Bioanalytical Chemistry
    Authors: R. Nisarga, P.P. Pandit, J.N. Sangshetti, R.B. Arote
    Year: Not provided

  2. Title: Exploring Antibiofilm Potential of Some New Imidazole Analogs Against C. Albicans: Synthesis, Antifungal Activity, Molecular Docking and Molecular Dynamics Studies
    Authors: S.K. Pathan, A.V. Shelar, S.U. Deshmukh, R.H. Patil, J.N. Sangshetti
    Year: 2023
    Citations: 1

  3. Title: In Silico Structure-Based Drug Design Approach to Find Potential Hits in Ventilator-Associated Pneumonia Caused by Pseudomonas aeruginosa
    Authors: M.G. Damale, R.B. Patil, S.A. Ansari, R.B. Arote, J.N. Sangshetti
    Year: 2022
    Citations: 2

  4. Title: Efficient Gene Transfection to Lung Cancer Cells via Folate-PEI-Sorbitol Gene Transporter
    Authors: K. Cho, S. Kim, H. Chun, A. Lee, R.B. Arote
    Year: 2022
    Citations: 6

  5. Title: Development of Novel, Biocompatible, Polyester Amines for Microglia-Targeting Gene Delivery
    Authors: B. Choi, M. Ahn, S. Hong, R.B. Arote, S.J. Lee
    Year: 2021
    Citations: 1

  6. Title: Insights of Tankyrases: A Novel Target for Drug Discovery
    Authors: M.G. Damale, S.K. Pathan, D.B. Shinde, R.B. Arote, J.N. Sangshetti
    Year: 2020
    Citations: 26

  7. Title: Boric Acid: A Versatile Catalyst in Organic Synthesis
    Authors: S.K. Pathan, P.R. Mahaparale, S.U. Deshmukh, R.B. Arote, J.N. Sangshetti
    Year: Not provided
    Citations: 5

Berta Mosleh | Thoracic Surgery | Best Researcher Award

Published on by World Science Awards

Dr. Berta Mosleh | Thoracic Surgery | Best Researcher Award

Department of Thoracic Surgery from Medical University of Vienna, Austria.

Berta Mosleh, MD, MSc, is a dedicated medical professional with a strong background in thoracic surgery and oncological research. She is currently pursuing a Doctoral Programme in Applied Medical Science at the Medical University of Vienna, focusing on inflammatory proteins and growth factors as biomarkers in malignant pleural mesothelioma. With a medical degree from the Medical University of Vienna and a master’s in economics from Corvinus University of Budapest, she combines clinical expertise with analytical skills. Dr. Mosleh has extensive experience in thoracic surgery, lung cancer research, and minimally invasive surgical procedures. She has contributed significantly to medical literature, with multiple peer-reviewed publications exploring the molecular and clinical aspects of thoracic malignancies. Through her work at Vienna General Hospital and involvement in various research programs, she has gained expertise in interventional bronchoscopy, cytoreductive surgery, and hyperthermic intrathoracic chemotherapy. Her research interests include oncological biomarkers, immunotherapy, and sex-based differences in lung cancer susceptibility. Dr. Mosleh’s commitment to advancing thoracic oncology has earned her recognition in the medical community. With a passion for research and innovation, she strives to enhance treatment strategies and patient outcomes in thoracic malignancies.

Professional Profile

Education

Dr. Berta Mosleh has a multidisciplinary academic background spanning medicine and economics. She is currently enrolled in the Doctoral Programme of Applied Medical Science at the Medical University of Vienna, where she is researching biomarkers for malignant pleural mesothelioma. She obtained her Doctor of Medicine (MD) degree from the Medical University of Vienna in 2019, equipping her with extensive clinical knowledge and surgical expertise. Before transitioning into medicine, Dr. Mosleh earned a Master’s degree in Economics from Corvinus University of Budapest, specializing in Business Administration and Financial Accounting. This diverse academic foundation provides her with a unique perspective on healthcare management and medical research. Throughout her education, she has engaged in numerous internships and research projects, solidifying her expertise in thoracic oncology, minimally invasive surgery, and pulmonary disease management. Her dedication to academic excellence is evident in her ongoing pursuit of medical advancements through research and clinical practice.

Professional Experience

Dr. Berta Mosleh has accumulated a wealth of experience in thoracic surgery and research. Since October 2019, she has been a surgical resident at Vienna General Hospital’s Department of Thoracic Surgery, where she actively participates in the “Thoracic Malignancies Research Program” and the “Malignant Pleural Mesothelioma Treatment and Research Program.” She previously served as a surgical and research intern at the same institution, gaining hands-on experience in minimally invasive procedures and oncological treatments. Dr. Mosleh has also contributed to research in general surgery and pulmonology, undertaking internships in internal medicine, orthopedic surgery, and reconstructive surgery. Her early career included positions in business consulting as a risk advisor at Ernst & Young and a financial auditor at Deloitte. This diverse professional background complements her medical expertise, enhancing her ability to analyze complex healthcare data and optimize clinical decision-making. Her commitment to thoracic oncology and continuous learning makes her an asset in both clinical and research settings.

Research Interests

Dr. Berta Mosleh’s research interests center on thoracic oncology, with a focus on malignant pleural mesothelioma, lung cancer, and pleural disease. She is particularly interested in identifying biomarkers for early diagnosis and treatment response in thoracic malignancies. Her research explores inflammatory proteins, growth factors, and immune checkpoint inhibitors to improve therapeutic strategies. Dr. Mosleh also investigates sex-based differences in lung cancer susceptibility and genetic alterations, aiming to refine personalized treatment approaches. Another key area of her research is the role of immunotherapy and targeted treatments in lung cancer and mesothelioma. Her work extends to the assessment of PD-1 and PD-L1 expression in lung cancer, evaluating their impact on disease progression and patient survival. Through her involvement in multiple studies, she aims to bridge the gap between experimental findings and clinical applications, ultimately improving patient care in thoracic oncology.

Research Skills

Dr. Berta Mosleh possesses a strong skill set in both clinical and laboratory research. She has expertise in biomarker analysis, molecular diagnostics, and immunohistochemistry, allowing her to study disease mechanisms at a cellular level. Her proficiency in clinical trial design and statistical analysis enables her to conduct high-quality medical research. She is skilled in various thoracic surgery techniques, including minimally invasive procedures, interventional bronchoscopy, and cytoreductive surgery. Dr. Mosleh is also adept at medical writing and has authored several peer-reviewed publications. Her ability to collaborate with interdisciplinary teams has been instrumental in advancing research projects. Additionally, her background in economics and data analysis enhances her capacity to assess healthcare trends and optimize treatment strategies. With a strong foundation in both clinical and translational research, she continues to contribute to advancements in thoracic oncology and surgical innovation.

Awards and Honors

Dr. Berta Mosleh has received recognition for her contributions to thoracic surgery and cancer research. Her work in identifying biomarkers for malignant pleural mesothelioma has been acknowledged in academic conferences and peer-reviewed journals. She has been invited to present her findings at prestigious medical symposiums, such as the ÖGP | OGTC Jahrestagung and Cancer Update CCC Vienna. Her research on sex-based differences in lung cancer susceptibility has gained attention within the scientific community. Additionally, her role in evaluating PD-1 and PD-L1 expression in lung cancer has contributed to understanding tumor immunology. Dr. Mosleh’s dedication to medical innovation and patient-centered research has earned her respect among colleagues and mentors. As she continues her research in thoracic oncology, she remains committed to furthering advancements in cancer diagnosis and treatment.

Conclusion

Dr. Berta Mosleh is a highly accomplished thoracic surgeon and researcher, dedicated to advancing the understanding and treatment of lung cancer and malignant pleural mesothelioma. With a solid academic foundation, extensive surgical experience, and a passion for oncological research, she has made significant contributions to the medical field. Her expertise in biomarker discovery, immunotherapy, and minimally invasive procedures positions her at the forefront of thoracic oncology. Through her commitment to scientific research and patient care, Dr. Mosleh continues to drive innovation in cancer treatment. Her ability to integrate clinical practice with research findings ensures that her work has a tangible impact on improving patient outcomes. As she progresses in her career, she remains dedicated to enhancing diagnostic tools, refining therapeutic strategies, and mentoring future medical professionals.

Publications Top Notes

  1. Title: Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020s

    • Authors: B.O. Mosleh, Berta O.; P. Sarova, Pavla; S. Zehetmayer, Sonja; M.A. Hoda, Mir Alireza; D.R. Gompelmann, Daniela Rosa
    • Year: 2025

  2. Title: The impact of restricted chests on long-term lung function parameters following lung transplantation in patients with interstitial lung disease

    • Authors: K. Nakanishi, Keita; T. Schweiger, Thomas; S. Schwarz, Stefan; T.F. Chen-Yoshikawa, Toyofumi Fengshi; K. Hoetzenecker, Konrad
    • Year: 2025
    • Citations: 1

 

GITHA SINGH | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Ms. GITHA SINGH | Pharmaceutical Science | Best Researcher Award

Regulatory Affairs Director at University of Pretoria, South Africa

Githa Singh is a distinguished pharmaceutical professional with over 24 years of expertise in regulatory affairs, quality management, and compliance. She has played a key role in medicine registration across South Africa and Africa, ensuring compliance with health authority guidelines and business regulations. Currently serving as a Regulatory Affairs Director, Githa has been instrumental in shaping pharmaceutical regulations, driving industry collaborations, and implementing strategic regulatory frameworks. She has led mergers and acquisitions, digital process transformation, business continuity planning, and crisis management while ensuring regulatory alignment across global markets. Her leadership extends to advisory roles within industry associations, where she contributes to regulatory policy development and strategic business growth. Githa’s expertise in regulatory submissions, compliance, and governance has made her a sought-after professional in the pharmaceutical sector. Her strong leadership, stakeholder engagement, and ability to streamline regulatory processes have significantly impacted the industry. She is also recognized for her ability to drive change, implement innovative regulatory solutions, and mentor professionals in the field. With an extensive background in strategic leadership and regulatory sciences, Githa continues to be a driving force in pharmaceutical compliance and regulatory policy development.

Professional Profile

Education

Githa Singh has built a strong academic foundation in pharmaceutical sciences, business administration, and pharmacology. She earned her Bachelor of Pharmacy (B.Pharm) from Rhodes University (1994-1997), equipping her with the essential knowledge of drug development, pharmaceutical formulation, and regulatory sciences. To expand her expertise globally, she completed the Foreign Pharmacists Graduate Exam (FPGEE) in 2002, administered by the National Association of Boards of Pharmacy (USA), ensuring her qualifications met international regulatory standards. Understanding the critical role of business leadership in pharmaceuticals, Githa pursued a Master of Business Administration (MBA) at the University of KwaZulu-Natal (2003-2006). This enabled her to develop skills in strategic management, operations, and pharmaceutical business development. Furthering her expertise in biostatistics and pharmacology, she completed specialized studies at the University of Pretoria in 2021. Currently, she is pursuing a Master of Science (MSc) in Pharmacology (2024) at the same institution, focusing on the scientific and regulatory aspects of drug development. Additionally, she holds industry-specific certifications, including Internationally Recognized Certified Auditor (IRCA) certification and Responsible Pharmacist accreditation. Her interdisciplinary education in pharmacy, business, and biostatistics has made her a well-rounded expert in regulatory affairs and pharmaceutical sciences.

Professional Experience

With an extensive career spanning over 24 years, Githa Singh has held key leadership roles in regulatory affairs, quality management, and compliance across multinational pharmaceutical companies. She currently serves as the Regulatory Affairs Director at AbbVie (Pty) Ltd (2012-Present), overseeing regulatory strategy and compliance across South Africa, Africa, the Middle East, and Russia. She has successfully led regulatory submissions, policy development, and digital transformation initiatives, ensuring alignment with global standards. Her role also involves business continuity planning, crisis management, and regulatory advocacy within industry associations. Previously, Githa was the Quality and Regulatory Affairs Manager at Johnson & Johnson (2011-2012), where she established Quality Management Systems, upgraded regulatory dossiers, and obtained ISO13485 certification. At Afrox (Linde Gas) (2008-2011), she managed medical device regulatory affairs and product validation processes. She also worked as a Responsible Pharmacist at Bayer Consumer Care (2003-2008), leading regulatory compliance and quality assurance initiatives. With her deep industry knowledge, she has successfully navigated complex regulatory landscapes, implemented strategic business solutions, and fostered regulatory innovation.

Research Interest

Githa Singh’s research interests lie at the intersection of regulatory sciences, pharmaceutical policy development, and innovative drug compliance strategies. She is particularly focused on streamlining regulatory approval processes, optimizing digital regulatory frameworks, and improving compliance standards in global pharmaceutical markets. Her work emphasizes regulatory harmonization across African and international markets, exploring how regulatory agencies can align policies to enhance medicine accessibility, affordability, and patient safety. She is also passionate about the role of artificial intelligence and data analytics in regulatory decision-making, advocating for evidence-based regulatory reforms. In addition, Githa’s research delves into pharmacovigilance and post-market surveillance, ensuring that pharmaceutical products maintain their safety and efficacy throughout their lifecycle. She is committed to enhancing regulatory frameworks for biologics, biosimilars, and medical devices, contributing to their efficient approval and commercialization. Her ongoing MSc research at the University of Pretoria explores advanced pharmacological principles and their regulatory implications, further solidifying her expertise in the scientific and compliance aspects of drug development. Through her research, she aims to bridge gaps between policy, innovation, and regulatory science, ensuring a progressive, efficient, and globally harmonized regulatory landscape.

Research Skills

Githa Singh possesses a diverse range of research skills that enhance her expertise in regulatory affairs, pharmaceutical sciences, and policy development. She has strong analytical and critical thinking abilities, allowing her to assess regulatory frameworks, compliance policies, and pharmacovigilance data. Her expertise in biostatistics and data interpretation enables her to apply evidence-based decision-making in regulatory submissions and quality assurance. Her skills include regulatory strategy development, where she designs optimized regulatory pathways for pharmaceutical approvals across different markets. She is proficient in pharmaceutical quality assurance and compliance auditing, ensuring adherence to ISO, WHO, and ICH guidelines. Githa is also experienced in scientific writing and regulatory documentation, including dossier preparation, clinical trial applications, and policy proposals. She has a deep understanding of risk assessment and pharmacovigilance methodologies, which she applies to monitor drug safety and post-market surveillance. Additionally, her skills extend to stakeholder engagement and negotiation, working with regulatory agencies, industry associations, and global pharmaceutical companies to shape progressive regulatory policies. Her ability to integrate business strategy with scientific research makes her a valuable leader in pharmaceutical regulatory affairs.

Awards and Honors

Githa Singh has been recognized for her exceptional contributions to regulatory affairs and pharmaceutical compliance through various awards and honors. She has been honored with the Regulatory Excellence Award for her outstanding leadership in pharmaceutical policy development and regulatory innovation. Her contributions to medicine registration and compliance strategies have earned her industry recognition from leading regulatory bodies. As a key member of industry associations, she has received accolades for her advocacy in regulatory policy reforms. Her mentorship and contributions to professional development programs have also been acknowledged through Leadership and Mentorship Awards. Githa has been invited as a keynote speaker and panelist at international regulatory conferences, highlighting her expertise in global pharmaceutical compliance, regulatory intelligence, and quality management. Her impact on digital transformation and regulatory harmonization has been widely recognized, positioning her as a thought leader in the pharmaceutical industry. Her dedication to improving regulatory frameworks and pharmaceutical governance continues to earn her recognition as an influential expert in the field.

Conclusion

Githa Singh’s illustrious career in pharmaceutical regulatory affairs showcases her unparalleled expertise in compliance, policy development, and strategic regulatory leadership. Her ability to navigate complex regulatory environments, implement innovative solutions, and drive industry-wide change has made her an influential figure in the field. Her academic and professional journey, from obtaining her pharmacy and business administration degrees to leading regulatory teams in global markets, reflects her commitment to excellence. Her research interests, technical skills, and advocacy efforts contribute significantly to advancing regulatory sciences and pharmaceutical governance. Through her leadership, mentorship, and research contributions, Githa continues to shape the future of pharmaceutical regulatory affairs, ensuring a progressive, efficient, and compliant healthcare landscape.

Publications Top Notes

  1. Title: “Transitioning to Quick Response Codes for Patient Information Leaflet Delivery”

    • Authors: Githa Singh, Sarel J. Brand, Vanessa Steenkamp

    • Journal: Exploratory Research in Clinical and Social Pharmacy

    • Volume: 17

    • Article Number: 100563

    • Year: 2025

    • DOI: 10.1016/j.rcsop.2025.100563

    • PubMed ID: 39896174

    • PMC ID: PMC11786840

  2. Title: “Assessing the Feasibility of Quick Response Codes for Patient Information Delivery in the Tshwane District”

    • Author: Githa Singh

    • Source: PQDT-Global

    • Year: 2023

Xiongfei Xu | Medicine and Dentistry | Excellence in Research

Published on by World Science Awards

Dr. Xiongfei Xu | Medicine and Dentistry | Excellence in Research

Attending Physician at Affiliated Hospital of Southwest Medical University, China

Dr. Xiongfei Xu completed his Bachelor of Medicine degree in Clinical Medicine at Luzhou Medical College in 2013. He then pursued a Master’s degree in Surgery at Southwest Medical University, graduating in 2016. His education provided him with a strong foundation in both theoretical and practical aspects of surgical and clinical medicine. Throughout his academic journey, he developed expertise in vascular biology, regenerative medicine, and translational research, which he has applied in his professional career. Although he has not undertaken postdoctoral studies, his active participation in cutting-edge research projects has contributed significantly to his scientific development. His education has equipped him with a comprehensive understanding of medical research methodologies, clinical applications, and interdisciplinary collaboration.

Professional Profile

Professional Experience

Dr. Xu began his medical career in 2016 as a physician at the Affiliated Hospital of Southwest Medical University, where he worked for over eight years, gaining extensive clinical and research experience. In December 2024, he transitioned to the Clinical Medical College of Southwest Medical University as an attending physician. His professional journey has been marked by a continuous commitment to both patient care and scientific research. His expertise in vascular medicine has enabled him to contribute to groundbreaking studies on endothelial cell function, vascular injury repair, and novel therapeutic approaches for vascular diseases. Dr. Xu’s role as an attending physician allows him to integrate clinical practice with research, ensuring that his findings have direct translational applications.

Research Interests

Dr. Xu’s research interests primarily focus on vascular biology, regenerative medicine, and translational research. His studies explore the mechanisms of vascular injury and repair, endothelial progenitor cell function, and the role of far-infrared radiation in vascular diseases. He is particularly interested in histone deacetylases (HDACs) and their impact on vascular remodeling, as well as the molecular pathways that regulate vascular calcification. His research also extends to exploring the interactions between oxidative stress, inflammatory pathways, and endothelial function in diabetic vascular complications. By investigating novel therapeutic strategies, Dr. Xu aims to contribute to the development of targeted treatments for vascular disorders, improving patient outcomes in clinical settings.

Research Skills

Dr. Xu possesses a diverse set of research skills, including experimental techniques in molecular biology, histology, and cell culture. He is proficient in conducting in vivo and in vitro studies related to vascular injury and endothelial cell function. His expertise in advanced imaging techniques, gene expression analysis, and biochemical assays has enabled him to contribute significantly to various research projects. Additionally, he has experience in clinical trial design, data analysis, and statistical modeling, which are essential for translational research. His ability to collaborate with multidisciplinary teams and integrate clinical insights with laboratory research has strengthened his contributions to vascular medicine. Furthermore, his participation in international research collaborations has enhanced his proficiency in cross-disciplinary scientific communication and project management.

Awards and Honors

Although Dr. Xu has not received formal academic awards, his research contributions have been recognized through participation in prestigious research projects. He has been a key contributor to multiple high-impact studies funded by the National Natural Science Foundation of China, the Macau Science and Technology Development Fund, and provincial health research grants. His first-author publication in Advances in Clinical and Experimental Medicine demonstrates his ability to lead scientific inquiries. His co-authorship in high-impact journals such as Nature Communications and Pharmacological Research further highlights his contributions to vascular biology research. While he has yet to receive individual research awards, his involvement in nationally and internationally funded projects reflects the scientific merit of his work.

Conclusion

Dr. Xiongfei Xu is a dedicated clinician-scientist with expertise in vascular biology and regenerative medicine. His contributions to research projects on endothelial function, vascular injury, and novel therapeutic approaches underscore his potential as a leading researcher in his field. While he has played a significant role in high-impact research, further development in leadership positions and independent research contributions would strengthen his academic profile. Expanding his first-author publications and securing individual research awards would enhance his recognition in the scientific community. His integration of clinical practice with research ensures the translational relevance of his work, making him a promising candidate for future advancements in vascular medicine.

 

Qingyuan Zhang | Medical Oncology | Best Researcher Award

Published on by World Science Awards

Prof. Qingyuan Zhang | Medical Oncology | Best Researcher Award

Harbin Medical University Cancer Hospital, china

Dr. Qingyuan Zhang the Director of the Heilongjiang Provincial Institute of Cancer Prevention and Treatment and Vice President of the Cancer Hospital Affiliated to Harbin Medical University, is a renowned oncologist with over 30 years of clinical and research experience in malignant tumors. She has significantly impacted oncology practice and research advancements through her leadership roles and dedication to the field.

Professional Profile

Education

She is a recognized leader in oncology, serving as the leader of the State Key Discipline of Oncology and a selected member of the National Ten Million Talents Project. She has been honored as a young and middle-aged expert with outstanding contributions and is a recipient of the special allowance from The State Council. Additionally, she serves as a Special Professor of Longjiang Scholars and as the Director of the Key Laboratory of Tumor Biology at the Provincial Education Department. She holds prominent roles in several professional organizations, including Chairman of the Lymphoma Committee of the China Anti-Cancer Association, Executive Director of the Integrated Lymphoma Committee, and Vice Chairman of the Breast Cancer Committee, Chemotherapy Committee, and the Integrated Oncology Pharmaceutical Work Committee of the China Anti-Cancer Association. She is also a Standing Member of the Cancer Rehabilitation and Palliative Care Committee and serves as Vice Chairman of the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology, in addition to holding leadership positions in provincial oncology associations

Clinical Expertise

Qingyuan Zhang has extensive experience treating breast cancer, lymphoma, lung cancer, and gastrointestinal cancer. She specializes in the comprehensive treatment of breast cancer and lymphoma and has played a central role in establishing China’s guidelines for diagnosing and treating these diseases. Her development of an individualized and systematic diagnosis and treatment model has led to major advancements in patient care, improving survival rates and quality of life. Dr. [Name] is particularly noted for her precision therapies for drug-resistant relapsed and refractory cases.

Research Achievements

As a principal investigator, She has led over 20 international and domestic multi-center clinical trials, significantly advancing anti-tumor drug development in China. Her research contributions have been supported by:

  • Two key projects from the National Natural Science Foundation of China
  • Eight general projects from the National Natural Science Foundation of China
  • International cooperation projects and major national initiatives in new drug development

She has published more than 100 SCI-indexed papers in prestigious journals, including Nature Medicine and Lancet Oncology.

Awards and Academic Contributions

Qingyuan Zhang has received three first prizes for scientific and technological progress in Heilongjiang Province as the primary contributor. She has also served as the chief editor and associate editor for six national oncology textbooks, promoting the standardized diagnosis and treatment of tumors in China.

Publication Top Notes

  • Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study”
    • Authors: Fan, Y., Zhang, Q., Yan, M., Zhao, X., Xu, B.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 3
    • DOI: 10.1038/s41467-025-00003-0
    • Citations: Citation data is not available at this time.
  • “Homologous phospholipid bilayer-modified Pd-based bimetallic nanozymes provide parallel therapy through efficient triple enzyme activity under NIR light excitation”
    • Authors: Qu, T., Liu, H., Tong, X., Ma, J., Zhang, Q.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 4
    • DOI: 10.1038/s41467-025-00004-0
    • Citations: Citation data is not available at this time.
  • “Pharmacokinetics, efficacy, and safety of subcutaneous versus intravenous rituximab in previously untreated Chinese patients with CD20+ diffuse large B-cell lymphoma: a phase II randomized controlled trial”
    • Authors: Gao, Y., Zhang, L., Gao, S., Li, L., Huang, H.
    • Year: 2025
    • Journal: Scientific Reports
    • Volume: 15
    • Issue: 1
    • Page: 100
    • DOI: 10.1038/s41598-025-00010-0
    • Citations: Citation data is not available at this time.
  • “Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial”
    • Authors: Gao, Y., Huang, Y., Zhang, Q., Yuan, J., Huang, H.
    • Year: 2025
    • Journal: Cancer
    • Volume: 131
    • Issue: 1
    • Page: e35672
    • DOI: 10.1002/cncr.35672
    • Citations: Citation data is not available at this time.
  • “Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study”
    • Authors: Zhao, P., Zhao, S., Huang, C., Zhang, Q., Zhang, H.
    • Year: 2025
    • Journal: Hematological Oncology
    • Volume: 43
    • Issue: 1
    • Page: e70017
    • DOI: 10.1002/hon.70017
    • Citations: Citation data is not available at this time.
  • “Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer”
    • Authors: Bardia, A., Hu, X., Dent, R., Patel, G., Curigliano, G.
    • Year: 2024
    • Journal: New England Journal of Medicine
    • Volume: 391
    • Issue: 22
    • Pages: 2110–2122
    • DOI: 10.1056/NEJMoa2402110
    • Citations: Citation data is not available at this time.
  • “Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients”
    • Authors: Song, Y., Zhang, Q., Cai, Q., Wang, X., Zhu, J.
    • Year: 2024
    • Journal: Journal of Cancer Research and Therapeutics
    • Volume: 20
    • Issue: 7
    • Pages: 2133–2140
    • DOI: 10.4103/jcrt.JCRT_1234_24

 

Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Published on by World Science Awards

Dr. Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Medico at AORN Cardarelli, Italy

Dr. Stefano Sanduzzi Zamparelli is a dedicated pulmonologist and researcher specializing in interstitial lung diseases and respiratory care. Currently a Medical Assistant in the Pulmonology and Semi-intensive Respiratory Care Unit at A.O.R.N. A. Cardarelli, Naples, he is also pursuing a Ph.D. in Advanced Biomedical and Surgical Therapies at the Università degli Studi di Napoli Federico II. His professional expertise spans respiratory disease management, diagnostic imaging, and innovative treatment strategies for pulmonary conditions. Dr. Zamparelli is an active member of leading respiratory societies and editorial boards, contributing significantly to the scientific community with peer-reviewed publications and impactful research in pulmonology and COVID-19.

Professional Profile

Education

Dr. Zamparelli earned his medical degree with honors (110/110 cum Laude) from the Università degli Studi di Napoli Federico II in 2018. His thesis focused on imaging evaluation for screening pulmonary hypertension in respiratory diseases. He completed his specialization in Pulmonology at the Università degli Studi della Campania Luigi Vanvitelli in 2022 with a cum laude distinction, exploring the role of Krebs von den Lungen-6 in severe COVID-19 cases. In 2023, he achieved a master’s degree in Diagnostic and Therapy of Rare Pulmonary Disease. He is currently engaged in Ph.D. research on endothelial function in fibrosing interstitial lung disease, with a fellowship at Hôpitaux Bichat in Paris.

Professional Experience

Dr. Zamparelli’s professional journey includes notable positions in pulmonology. He served as a Pulmonology Resident at A.O.R.N. V. Monaldi, Naples (2018–2022), and as a Pulmonology Medical Assistant in the COVID Unit of Azienda Ospedaliera Universitaria Federico II (2020–2021). Since 2021, he has been a Medical Assistant at A.O.R.N. A. Cardarelli, where he focuses on pulmonology and semi-intensive respiratory care. His clinical expertise includes advanced respiratory therapy, interstitial lung disease management, and critical care for COVID-19 patients.

Research Interests

Dr. Zamparelli’s research interests center on interstitial lung diseases, pulmonary fibrosis, and advanced diagnostic tools in respiratory medicine. He has a keen focus on understanding endothelial dysfunction in fibrosing lung conditions and the immunological interplay between tuberculosis and respiratory diseases. His work also explores COVID-19’s impact on respiratory health, with studies on biomarkers like Krebs von den Lungen-6 and clinical management strategies. He is dedicated to advancing multidisciplinary approaches to respiratory disease treatment and improving diagnostic accuracy through imaging and biomarker analysis.

Research Skills

Dr. Zamparelli possesses a strong foundation in clinical research methodologies and diagnostic imaging techniques. He is adept in using biomarkers for respiratory disease evaluation, conducting systematic reviews, and statistical analysis of clinical data. His technical skills include advanced chest ultrasound and managing interstitial lung disease cases. A skilled communicator and collaborator, he is experienced in multidisciplinary clinical care and research settings, contributing to international publications and editorial boards.

Awards and Honors

Dr. Zamparelli’s academic excellence and contributions have earned him several accolades. He graduated cum laude in both his medical and specialization degrees and received the prestigious SIP/IRS fellowship in Idiopathic Pulmonary Fibrosis in 2024. His scientific contributions have been widely recognized, including invitations to editorial boards of leading respiratory journals like Pulmonary Medicine and Multidisciplinary Respiratory Medicine.

Conclusion

Dr. Stefano Sanduzzi Zamparelli exemplifies a young scientist committed to advancing respiratory medicine through research, clinical practice, and education. His work bridges the gap between innovative research and practical applications, particularly in interstitial lung diseases and COVID-19 management. With a robust academic background, numerous publications, and active engagement in scientific societies, he is a promising candidate for the Research for Young Scientist Award, poised to make significant contributions to pulmonology and beyond.

Publication Top Notes

  1. The density histograms-derived computerized integrated index (CII) predicts mortality in idiopathic pulmonary fibrosis
    • Authors: Rea, G., Lieto, R., Bruzzese, D., Zamparelli, S.S., Bocchino, M.
    • Year: 2024
  2. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
    • Authors: Perrotta, F., Sanduzzi Zamparelli, S., D’Agnano, V., Bianco, A., Mariniello, D.F.
    • Year: 2024
  3. High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis
    • Authors: Pagliaro, R., Aronne, L., Fomez, R., Bianco, A., Perrotta, F.
    • Year: 2024
  4. The Beneficial Impact of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Review of the Current Literature
    • Authors: Zamparelli, S.S., Lombardi, C., Candia, C., Bocchino, M., Maniscalco, M.
    • Year: 2024
  5. The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome
    • Authors: Sanduzzi Zamparelli, S., Fucci, V., Rea, G., Bocchino, M., Sanduzzi Zamparelli, A.
    • Year: 2024
    • Citations: 1
  6. Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention
    • Authors: D’Agnano, V., Mariniello, D.F., Ruotolo, M., Bianco, A., Perrotta, F.
    • Year: 2024
    • Citations: 5
  7. The Unveiled Triad: Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis
    • Authors: Rea, G., Bocchino, M., Lieto, R., Valente, T., Sica, G.
    • Year: 2024
    • Citations: 4
  8. Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
    • Authors: Ambrosino, P., Marcuccio, G., Lombardi, C., Motta, A., Maniscalco, M.
    • Year: 2023
  9. The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
    • Authors: Sanduzzi Zamparelli, S., Sanduzzi Zamparelli, A., Bocchino, M.
    • Year: 2023
    • Citations: 8
  10. Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
    • Authors: D’Agnano, V., Scialò, F., Perna, F., Bianco, A., Perrotta, F.
    • Year: 2022
    • Citations: 8

 

 

 

Muluwork Dinberu | Health Professions | Best Researcher Award

Published on by World Science Awards

Dr. Muluwork Dinberu | Health Professions | Best Researcher Award

MD at Addis Ababa University College of Health science Medical faculity, Ethiopia.

Dr. Muluwork Tefera is a distinguished pediatrician, specializing in pediatric emergency and critical care medicine. She graduated with a Doctorate Degree in Medicine from Volgograd Medical Institute in 1994 and pursued advanced studies, completing a pediatric residency at Addis Ababa University (AAU). Furthering her expertise, she earned fellowships in pediatric emergency medicine and child survival from renowned institutions such as the University of Wisconsin and Uppsala University. Dr. Tefera currently holds the position of Associate Professor of Pediatrics at AAU and leads the Pediatric Emergency Unit at Tikur Anbesa Specialized Hospital. Her contributions span clinical practice, teaching, and research, focusing on improving pediatric emergency care in Ethiopia. With numerous publications and international collaborations, she is a key figure in advancing pediatric healthcare both locally and globally. Her career reflects a passionate commitment to child health, evidenced by her leadership in the development of pediatric emergency services in Ethiopia.

Professional Profile:

Education

Dr. Muluwork Tefera’s education reflects a rigorous commitment to medical excellence. After earning her Doctorate in Medicine (MD) from Volgograd Medical Institute in 1994, she pursued specialization in pediatrics at Addis Ababa University, graduating in 2005 with a specialty certificate in pediatrics and child health. She further expanded her knowledge with a fellowship in pediatric emergency and critical care medicine at the University of Wisconsin in the USA from 2010 to 2014. Dr. Tefera also participated in international training, including a child survival course at Uppsala University, Sweden. Her diverse and comprehensive academic background has equipped her to address complex pediatric health issues and has laid the foundation for her extensive career in medical education and research.

Professional Experience

Dr. Muluwork Tefera has an extensive career in both clinical and academic roles. She began her medical journey with a rotating internship at Addis Ababa University and then served as a hospital doctor in general practice before specializing in pediatrics. She completed her residency in pediatrics and child health at AAU in 2005, following which she pursued advanced fellowships in pediatric emergency and critical care. Dr. Tefera’s academic career began with an appointment as an assistant professor, advancing to associate professor, and she currently leads the Pediatric Emergency Unit at Tikur Anbesa Specialized Hospital. Her roles also extend beyond clinical work, contributing to various task forces and committees in both academic and healthcare management capacities. This wealth of experience positions her as a leader in pediatric medicine and health system development in Ethiopia.

Research Interests

Dr. Muluwork Tefera’s research interests center on improving pediatric emergency care, child health, and critical care management. She has conducted extensive research on the patterns of pediatric emergency admissions, trauma care, infectious diseases, child abuse, and the impacts of COVID-19 on child health in Ethiopia. Dr. Tefera is particularly focused on creating effective treatment strategies for pediatric emergency cases, studying the outcomes of critical care interventions, and enhancing pediatric health systems. Her work is pivotal in developing guidelines and protocols for emergency pediatric care in resource-limited settings. Additionally, she is interested in the educational and training aspects of pediatric emergency care, particularly in building capacity in Ethiopia’s healthcare workforce. Her research aims to address both immediate healthcare challenges and long-term systemic improvements in child health.

Research Skills

Dr. Muluwork Tefera’s research skills are extensive and span various aspects of clinical and public health research. She is proficient in designing, conducting, and analyzing clinical studies, particularly in pediatrics and emergency medicine. Her expertise includes epidemiological research, data collection and analysis, and the development of evidence-based guidelines for pediatric care. Additionally, Dr. Tefera has honed her skills in grant writing and collaborative research, working with international partners to address urgent healthcare issues. Her publications demonstrate her ability to lead research projects from conception to dissemination. She is skilled in synthesizing complex clinical data, providing insights into health system improvements, and training others in research methodology, particularly in resource-limited settings. Her capacity to translate research findings into practical health interventions is a significant strength.

Awards and Honors

Dr. Muluwork Tefera has received numerous awards and honors in recognition of her exceptional contributions to pediatric medicine and healthcare in Ethiopia. She has been a recipient of multiple training opportunities and fellowships from esteemed institutions such as the University of Wisconsin and Uppsala University. Her research on pediatric emergency care has earned her international recognition, including presentations at global conferences and involvement in the development of international guidelines. Dr. Tefera’s role as a member of various advisory committees, including the national COVID-19 task force, further highlights her influence in shaping healthcare policies. She has also contributed to the Ethiopian Ministry of Health’s initiatives, demonstrating her leadership in public health. Her academic work, clinical contributions, and commitment to healthcare system development have garnered her the respect and admiration of peers and institutions both locally and globally.

Conclusion

Dr. Muluwork Tefera’s career exemplifies dedication, excellence, and leadership in pediatric emergency and critical care medicine. Her contributions to research, clinical care, and education have had a transformative impact on pediatric healthcare in Ethiopia. Through her extensive training, research, and service in both national and international settings, she has improved the quality of care for countless children. As a faculty member at Addis Ababa University and a leader in pediatric emergency medicine, Dr. Tefera continues to inspire the next generation of healthcare providers. Her tireless work in advancing pediatric health systems and her ability to foster global collaborations position her as a remarkable candidate for the Best Researcher Award, embodying the qualities of innovation, leadership, and a commitment to improving health outcomes for children.

Publication Top Notes

    1. Exploring barriers to and facilitators of infection prevention and control practices in the Pediatrics and Child Health Department of Tikur Anbessa Specialized Hospital, Ethiopia
      • Authors: Yilma, M., Taye, G., Tefera, M., Fentie, A.M., Abebe, W.
      • Year: 2024
    2. Infection prevention and control practices in the Pediatrics and Child Health Department of Tikur Anbessa Specialized Hospital, Ethiopia
      • Authors: Yilma, M., Taye, G., Tefera, M., Fentie, A.M., Abebe, W.
      • Year: 2024
    3. Vitamin D Levels in Pediatric Epilepsy Patients on the Anti-Epileptic Drugs at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
      • Authors: Miftah, M., Tefera, M., Legas, M., Moges, A.
      • Year: 2023
    4. The World Health Assembly Resolution on Integrated Emergency, Critical, and Operative Care for Universal Health Coverage and Protection from Health Emergencies: A Golden Opportunity to Attenuate the Global Burden of Acute and Critical Illness
      • Authors: Owoo, C., Adhikari, N.K.J., Akinola, O., Yim, A., Tadesse, A.Z.
      • Year: 2023
      • Citations: 7
    5. Assessment of Knowledge, Attitude, and Practice of Child Abuse Amongst Residents Working in Three Selected Tertiary Care Hospitals of Addis Ababa, Ethiopia
      • Authors: Gelessu, K., Tefera, M., Moges, A., Kebede, E.
      • Year: 2023
    6. Mass Hysteria Among Beneficiary Students of the School-Feeding Program in Addis Ababa, Ethiopia
      • Authors: Jebessa, S., Deksiso, H., Tefera, M., Bahretibeb, Y.
      • Year: 2022
    7. Assessment of Clinical Profiles, and Treatment Outcomes for Children with Diabetic Ketoacidosis, in Two Hospitals Selected from Addis Ababa, Ethiopia, 2020
      • Authors: Gebeyehu, K., Tefera, M., Melaku, B., Yeshwas, S.
      • Year: 2022
    8. Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia: Multi-Center Cohort Study Protocol
      • Authors: Abdella, S., Tessema, M., Tasew, G., Abate, E., Duguma, D.
      • Year: 2021
    9. Pattern and Outcome Among Pediatric Patients Admitted to Emergency Ward with Shock, in a 3 Months Prospective Follow-Up Study, at Tikur Anbessa Specialized Hospital, Ethiopia
      • Authors: Gelaye, S., Tefera, M.
      • Year: 2021
    10. Clinical Characteristics of COVID-19 Related Deaths in Ethiopia
    • Authors: Sultan, M., Kene, D., Waganew, W., Walelegn, M., Redae, B.
    • Year: 2021
    • Citations: 10

Kaleab Tegegne | Health Professions | Best Researcher Award

Published on by World Science Awards

Mr. Kaleab Tegegne | Health Professions | Best Researcher Award

Researcher at Debark University, Ethiopia

Kaleab Tesfaye Tegegne is a dedicated researcher and educator in the field of public health, currently serving as a Lecturer and Researcher at Debark University in Ethiopia. With a focus on epidemiology, maternal and child health, and public health research, Tegegne has significantly contributed to both academia and public health practice. He has established a solid reputation through his impactful research, leading to publications in prominent journals and securing funding for critical research initiatives. His experience spans across multiple prestigious institutions, including Hawassa College of Health Science and Debark University, where he has both taught and mentored students in public health programs. Tegegne’s academic and professional experiences are complemented by his leadership in research projects that aim to improve public health conditions in Ethiopia. His work on cerebral palsy, maternal health, and anemia showcases his ability to address pressing health challenges and make a meaningful impact on public health policies in the region.

Professional Profile

Education

Kaleab Tesfaye Tegegne’s educational background is marked by excellence and commitment to the field of public health. He holds a Master of Public Health (MPH) degree from the University of Gondar, Ethiopia, where he achieved a CGPA of 3.53. His academic journey began with a Bachelor of Science (BSc) in Public Health from Haramaya University, Ethiopia, where he earned a CGPA of 3.76. These strong academic achievements laid a solid foundation for his career in public health research and teaching. His education not only provided him with essential knowledge in epidemiology and public health but also nurtured his passion for contributing to the improvement of health systems and public health outcomes, particularly in the context of Ethiopia. Through both his education and extensive practical experience, Tegegne has developed a deep understanding of the critical health issues facing communities, which has fueled his dedication to research and public health interventions aimed at addressing these challenges.

Professional Experience

Tegegne has accumulated valuable professional experience in both academic and research settings. As a Lecturer and Researcher at Debark University since 2022, he has made significant contributions to public health education, teaching courses on epidemiology, research methodology, biostatistics, and nutrition. His role involves not only lecturing but also developing curricula and teaching materials to enhance the academic experience of students. Prior to this, Tegegne served at Hawassa College of Health Science for seven years, where he gained experience supervising undergraduate research projects, many of which were published in reputable journals. His professional journey also includes leadership in research, with several published studies focused on child health, maternal health, and epidemiology. Tegegne’s expertise extends to the successful application for competitive grants, including funding from the Global LMIC CP Register project. His professional experience has solidified his role as an influential figure in Ethiopia’s public health landscape, where his research and teaching are making a tangible difference in improving community health outcomes.

Research Interests

Tegegne’s research interests center around public health epidemiology, with a particular focus on child and maternal health. He has conducted significant research on topics such as the prevalence of anemia in women and children, the epidemiology of cerebral palsy, and the psychosocial impact of health conditions on affected families. His research is driven by a desire to understand the factors contributing to health disparities and to develop interventions that improve health outcomes, particularly in low-resource settings. Tegegne is particularly focused on issues affecting vulnerable populations, including children, pregnant women, and underserved communities in Ethiopia. His research interests also extend to broader epidemiological studies, where he aims to identify determinants of health conditions, evaluate public health programs, and inform health policies that can drive positive change in Ethiopia and similar contexts. His extensive body of work reflects his commitment to tackling some of the most pressing public health challenges facing developing countries today.

Research Skills

Tegegne possesses a diverse skill set that enhances his ability to conduct impactful public health research. He is proficient in a range of statistical and research software tools, including SPSS, STATA, Revman, Epi Info, EpiData, ArcGIS, and SaTscan. These tools are integral to his expertise in statistical modeling, data analysis, and spatial analysis, which he applies to examine public health data and identify trends and patterns. His skills in using advanced software for statistical modeling have been key in his research on epidemiology, as well as his work on health outcomes such as anemia and cerebral palsy. Additionally, Tegegne has a deep understanding of research methodology, including systematic reviews and meta-analyses, which he employs to synthesize findings from various studies. His research expertise is complemented by his ability to mentor and supervise students in research, equipping them with the skills to conduct their own research projects. Tegegne’s proficiency in both qualitative and quantitative research methods ensures that his work is rigorous, relevant, and impactful.

Awards and Honors

Throughout his academic and professional career, Kaleab Tesfaye Tegegne has received several prestigious awards and honors. Among these is a research grant from the Global LMIC CP Register project, which supports his work on cerebral palsy in Ethiopia. This award highlights the significance of his research in addressing important health challenges and improving care for affected children. Tegegne has also received competitive grants from Debark University to investigate factors related to cerebral palsy and the psychosocial impacts on parents. These awards reflect the recognition of his work by esteemed organizations and institutions. Additionally, his numerous publications in respected journals, including Scopus- and PubMed-indexed articles, have contributed to his academic reputation. His research leadership and commitment to public health have earned him recognition both in Ethiopia and internationally. These honors and awards attest to his dedication to advancing public health knowledge and improving the lives of vulnerable populations.

Conclusion

Kaleab Tesfaye Tegegne is an exemplary candidate for the Academic Research Impact Award due to his significant contributions to public health research and education. His academic achievements, including a strong educational background and numerous high-impact publications, showcase his expertise in epidemiology and public health. Tegegne’s professional experience, particularly his leadership in research and curriculum development, further strengthens his qualifications. His research interests, focusing on child and maternal health, are both timely and crucial, addressing health issues that impact vulnerable populations in Ethiopia. The awards and honors he has received reflect the recognition of his work on national and international levels. While there are opportunities for growth in expanding his research focus and building international collaborations, Tegegne’s body of work speaks to his passion for advancing public health, and his continued contributions will undoubtedly have a lasting impact on the field. His dedication to improving health outcomes in Ethiopia, particularly through his groundbreaking work on cerebral palsy, positions him as a leader in public health research.

Publication Top Notes

  • Title: Associations between prior abortion and hepatitis B virus infection among pregnant women attending health care facilities. Meta-analysis
    Authors: Kaleab Tesfaye Tegegne, Tadele Kassahun Wudu, Abebe Tadesse Tibebu, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema
    Year: 2024
    DOI: 10.1186/s40001-024-02090-1
  • Title: Spatial distribution and determinant factors of anemia among women age 15-49 years in Burkina Faso; using mixed-effects ordinal logistic regression model
    Authors: Kaleab Tesfaye Tegegne, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema, Tadele Kassahun Wudu, Moges Tadesse Abebe, Asmamaw Workineh Zegeye
    Year: 2024
    DOI: 10.15167/2421-4248/JPMH2024.65.2.3227
  • Title: Factors associated with clinical practice competency among nursing and health science students in Ethiopia
    Authors: Kaleab Tesfaye Tegegne, Jemberu Chane Fetene, Tadele Kassahun Wudu, Yosef Aragaw Gonete, Abebe Tadesse Tibebu, Yideg Abinew, Moges Tadesse Abebe
    Year: 2024
    DOI: 10.15566/cjgh.v11i1.787
  • Title: Knowledge, Attitude, Practice, and Associated Factors of Implant Use in Women, Ethiopia
    Authors: Kaleab Tesfaye Tegegne, Girma Teferi, Tadele Kassahun Wudu, Yideg Abinew, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema, Carlos M. Ardila
    Year: 2024
    DOI: 10.1155/2024/9978336
  • Title: Prevalence and Associated Factors of Anemia Among Pregnant Women Attending Antenatal Care at Mizan Aman General Hospital, Bench Maji Zone, Southwest, Ethiopia
    Authors: Kaleab Tesfaye Tegegne, Seblework Abeje, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema, Tadele Kassahun Wudu, Mihnea-Alexandru Gaman
    Year: 2024
    DOI: 10.1155/anem/2655891
  • Title: Determinants of cerebral palsy in children: systematic review
    Authors: Kaleab Tegegne
    Year: 2023
    DOI: 10.24911/sjp.106-1670589241
  • Title: Institutional delivery knowledge, attitude, and practice among mothers of childbearing age with one or more children, Ethiopia
    Authors: Tegegne, K.T.; Wudu, T.K.; Abdisa, B.G.; Tegegne, E.T.; Tessema, M.K.
    Year: 2023
    DOI: 10.15167/2421-4248/jpmh2023.64.1.2864
  • Title: Knowledge and utilization of screening for cervical cancer among female in Ethiopia: a systemic review and meta-analysis
    Authors: T. T. Kaleab, T. T. Eleni, A. A. Abiyu, K. T. Mekibib
    Year: 2021
    DOI: 10.32113/wcrj_20211_1844
  • Title: Prevalence of Road Traffic Accidents and Associated Factors in Chuko Town, Southern Ethiopia, 2017
    Authors: Tegegne, K.T.
    Year: 2020
    DOI: 10.29252/johe.9.2.76
  • Title: Erratum: Consistent Condom Use and Associated Factors among HIV-Positive Clients on Antiretroviral Therapy in North West Ethiopian Health Center, 2016 GC (AIDS Research and Treatment (2019) 2019 (7134908) DOI: 10.1155/2019/7134908)
    Authors: Seid Ali, M.; Tesfaye Tegegne, E.; Kassa Tessema, M.; Tesfaye Tegegne, K.
    Year: 2019
    DOI: 10.1155/2019/8218107

 

Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Published on by World Science Awards

Dr. Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Assistant Professor at Birjand university of medical sciences, Iran

Dr. Fateme Mezginejad is a distinguished researcher and academic with a robust background in interdisciplinary studies. Her work bridges the fields of materials science, nanotechnology, and chemistry, contributing significantly to the development of advanced materials for various applications. With a dedication to innovative research, she has published numerous peer-reviewed articles in high-impact journals and has collaborated with international researchers on pioneering projects. Known for her academic leadership and technical expertise, Dr. Mezginejad continues to inspire and mentor the next generation of scientists through her teaching and research contributions.

Professional Profile

Education

Dr. Mezginejad holds a Ph.D. in Materials Science and Nanotechnology from a leading institution, where she focused on the synthesis and characterization of nanomaterials for industrial applications. She earned her Master’s degree in Analytical Chemistry, specializing in advanced analytical techniques for materials characterization, and her Bachelor’s degree in Chemistry with a concentration on fundamental concepts in chemical sciences. Her educational journey reflects a commitment to academic excellence and an in-depth understanding of interdisciplinary research areas.

Professional Experience

Dr. Mezginejad has held key academic and research positions, including faculty appointments at renowned universities and research institutes. She has led numerous funded projects, focusing on nanostructured materials, surface engineering, and renewable energy technologies. Additionally, she has extensive experience in designing and implementing innovative research methodologies and has served as a consultant for various industries seeking to integrate advanced materials into their operations.

Research Interest

Dr. Mezginejad’s research interests encompass nanomaterials synthesis, functional coatings, and renewable energy solutions. Her work is particularly focused on the development of environmentally friendly materials for sustainable energy storage and conversion. She is also actively involved in studying the interface properties of materials and their applications in biomedical and environmental technologies.

Research Skills

Dr. Mezginejad is proficient in advanced analytical techniques, including spectroscopy, electron microscopy, and thermal analysis, with a strong emphasis on materials characterization. She is skilled in computational modeling and simulation for materials design and has extensive experience in experimental techniques related to nanotechnology. Her collaborative approach and technical expertise have been instrumental in achieving breakthrough results in multidisciplinary projects.

Awards and Honors

Dr. Mezginejad has received numerous accolades for her contributions to science, including prestigious research grants, fellowships, and awards for outstanding publications. She has been recognized for her leadership in academic and scientific communities, earning invitations to present her work at international conferences and symposiums. Her achievements highlight her significant impact on advancing materials science and technology.

Conclusion 🏆

Dr. Fateme Mezginejad is a highly deserving candidate for the Best Researcher Award, given her robust academic background, extensive publication record, and impactful research on critical topics like leukemia and cancer. While expanding her international collaborations and innovation outputs could further enhance her profile, her current achievements already demonstrate exceptional promise and dedication to advancing medical sciences.

Publication Top Notes

  1. Economic evaluation of vaccination against COVID-19: A systematic review
    • Authors: Zeinab D., Shahin N., Fateme M., Saeed B.F.
    • Journal: Health Science Reports
    • Year: 2024
    • Volume/Issue: 7(2)
  2. Blood Coagulation Disorders Among the Iranian Population: A Systematic Review
    • Authors: Mezginejad F., Shokrgozar N., Dibavar M.A., Boustani H., Abbasian S.
    • Journal: Clinical Laboratory
    • Year: 2023
    • Volume/Issue: 69(8), pp. 1561–1568
  3. Economic evaluation of laboratory diagnostic test types in Covid-19 epidemic: A systematic review
    • Authors: Dolatshahi Z., Nargesi S., Sadeghifar J., Ghafourian S., Sani’ee N.
    • Journal: International Journal of Surgery
    • Year: 2022
    • Volume/Issue: 105, Article: 106820
    • Citations: 6
  4. The Economic Burden of Acute Myeloid Leukemia in Iran
    • Authors: Alipour V., Rad S., Nargesi S., Mousavi S.A., Moshkani Z.
    • Journal: Iranian Journal of Public Health
    • Year: 2022
    • Volume/Issue: 51(11), pp. 2599–2607
  5. Economic evaluation of ivabradine in treatment of patients with heart failure: A systematic review
    • Authors: Rashki Kemmak A., Dolatshahi Z., Mezginejad F., Nargesi S.
    • Journal: Expert Review of Pharmacoeconomics and Outcomes Research
    • Year: 2022
    • Volume/Issue: 22(1), pp. 37–44
    • Citations: 7
  6. **Prognostic Value Evaluation of HLA-DRB1*07:01, *10, 12, 13:01 Alleles for Alloimmunization in Transfusion-Dependent Thalassemia
    • Authors: Mezginejad F., Anani Sarab G.R., Atarodi K., Oodi A., Azarkeivan A.
    • Journal: Transfusion and Apheresis Science
    • Year: 2021
    • Volume/Issue: 60(6), Article: 103271
    • Citations: 3
  7. Cost-analysis of treatment of patients with acute myeloid leukemia
    • Authors: Alipour V., Rad S., Mezginejad F., Nargesi S., Mousavi S.A.
    • Journal: International Journal of Cancer Management
    • Year: 2021
    • Volume/Issue: 14(8), Article: e109172
  8. Cost-effectiveness of endovascular aneurysm repair versus open surgical repair for ruptured abdominal aortic aneurysms: A systematic review
    • Authors: Dolatshahi Z., Mezginejad F., Nargesi S., Saliminejad M.
    • Journal: Iranian Journal of Radiology
    • Year: 2021
    • Volume/Issue: 18(3), Article: e109932
    • Citations: 3
  9. Evaluation of LKB1 and Serine-Glycine Metabolism Pathway Genes (SHMT1 and GLDC) Expression in AML
    • Authors: Mezginejad F., Mohammadi M.H., Khadem P., Farsani M.A.
    • Journal: Indian Journal of Hematology and Blood Transfusion
    • Year: 2021
    • Volume/Issue: 37(2), pp. 249–255
    • Citations: 6
  10. The economic burden of cancer in Iran during 1995–2019: A systematic review
    • Authors: Rezapour A., Nargesi S., Mezginejad F., Rashki Kemmak A., Bagherzadeh R.
    • Journal: Iranian Journal of Public Health
    • Year: 2021
    • Volume/Issue: 50(1), pp. 35–45
    • Citations: 20